Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (441-450 of 560) with videos related to

Pageof 56
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|February 3, 2019
Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer DetectionAmy P N Skubitz, Kristin L M Boylan, Kate Geschwind, et al.
The New England Journal of Medicine|April 7, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantationS J Brandt, W P Peters, S K Atwater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Autologous bone marrow transplantation for acute lymphoblastic leukemiaS E Sallan, C M Niemeyer, A L Billett, et al.
Oncotarget|February 27, 2016
Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκBMicaela Morgado, Margie N Sutton, Mary Simmons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancerZhen Lu, Robert Z Luo, Hongqi Peng, et al.
Cancer Research|March 5, 2004
A genetically defined model for human ovarian cancerJinsong Liu, Gong Yang, Jennifer A Thompson-Lanza, et al.
Cancer Research|June 1, 1991
Overexpression and mutation of p53 in epithelial ovarian cancerJ R Marks, A M Davidoff, B J Kerns, et al.
Cancer|November 13, 2019
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancerWei-Lei Yang, Zhen Lu, Jing Guo, et al.
FEBS Letters|June 25, 2013
Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical productionBregje van de Wier, Jiska M Balk, Guido R M M Haenen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 11, 2019
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian CancerArchana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, et al.
Pageof 56

Showing results (441-450 of 560) with videos related to

Sort By:
Pageof 56
Cancer Prevention Research (Philadelphia, Pa.)|February 3, 2019
Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer DetectionAmy P N Skubitz, Kristin L M Boylan, Kate Geschwind, et al.
The New England Journal of Medicine|April 7, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantationS J Brandt, W P Peters, S K Atwater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Autologous bone marrow transplantation for acute lymphoblastic leukemiaS E Sallan, C M Niemeyer, A L Billett, et al.
Oncotarget|February 27, 2016
Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκBMicaela Morgado, Margie N Sutton, Mary Simmons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancerZhen Lu, Robert Z Luo, Hongqi Peng, et al.
Cancer Research|March 5, 2004
A genetically defined model for human ovarian cancerJinsong Liu, Gong Yang, Jennifer A Thompson-Lanza, et al.
Cancer Research|June 1, 1991
Overexpression and mutation of p53 in epithelial ovarian cancerJ R Marks, A M Davidoff, B J Kerns, et al.
Cancer|November 13, 2019
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancerWei-Lei Yang, Zhen Lu, Jing Guo, et al.
FEBS Letters|June 25, 2013
Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical productionBregje van de Wier, Jiska M Balk, Guido R M M Haenen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 11, 2019
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian CancerArchana R Simmons, Evangelia Ourania Fourkala, Aleksandra Gentry-Maharaj, et al.
Pageof 56